5/28
08:14 am
neo
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management [Yahoo! Finance]
Low
Report
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management [Yahoo! Finance]
5/28
08:05 am
neo
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
Low
Report
NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
5/10
03:14 pm
neo
Kathryn McKenzie is Superfeet's New CFO — And the Third Woman in Shoes Named to the Top Finance Role This Week [Yahoo! Finance]
Low
Report
Kathryn McKenzie is Superfeet's New CFO — And the Third Woman in Shoes Named to the Top Finance Role This Week [Yahoo! Finance]
5/6
08:13 am
neo
Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 [Yahoo! Finance]
Low
Report
Komodo Health & Partners Present 33 Real-World Evidence Research Studies at ISPOR 2024 [Yahoo! Finance]
5/2
02:29 pm
neo
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/2
02:07 pm
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at BTIG Research from $23.00 to $21.00. They now have a "buy" rating on the stock.
Medium
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at BTIG Research from $23.00 to $21.00. They now have a "buy" rating on the stock.
5/2
06:39 am
neo
NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Medium
Report
NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
5/1
02:04 pm
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at TD Cowen from $21.00 to $20.00. They now have a "buy" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at TD Cowen from $21.00 to $20.00. They now have a "buy" rating on the stock.
5/1
11:41 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $18.00 price target on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $18.00 price target on the stock.
5/1
10:07 am
neo
NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $26.00 price target on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $26.00 price target on the stock.
4/30
01:19 pm
neo
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Needham & Company LLC from $24.00 to $19.00. They now have a "buy" rating on the stock.
Low
Report
NeoGenomics, Inc. (NASDAQ: NEO) had its price target lowered by analysts at Needham & Company LLC from $24.00 to $19.00. They now have a "buy" rating on the stock.
4/30
10:09 am
neo
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
Low
Report
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates [Yahoo! Finance]
4/30
07:39 am
neo
NeoGenomics Reports First Quarter 2024 Results [Yahoo! Finance]
High
Report
NeoGenomics Reports First Quarter 2024 Results [Yahoo! Finance]
4/30
07:30 am
neo
NeoGenomics Reports First Quarter 2024 Results
Medium
Report
NeoGenomics Reports First Quarter 2024 Results
4/18
07:27 am
neo
NeoGenomics announces senior leadership promotions [Seeking Alpha]
Low
Report
NeoGenomics announces senior leadership promotions [Seeking Alpha]
4/18
07:23 am
neo
NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]
Low
Report
NeoGenomics Announces Senior Leadership Promotions [Yahoo! Finance]
4/18
07:05 am
neo
NeoGenomics Announces Senior Leadership Promotions
Low
Report
NeoGenomics Announces Senior Leadership Promotions
4/9
07:00 am
neo
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
Medium
Report
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
3/27
08:33 am
neo
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]
Low
Report
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting [Yahoo! Finance]
3/27
08:30 am
neo
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
Low
Report
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
3/20
01:21 pm
neo
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy [Yahoo! Finance]
Low
Report
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy [Yahoo! Finance]
3/20
07:12 am
neo
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
Medium
Report
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report [Yahoo! Finance]
3/20
07:00 am
neo
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report
Medium
Report
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report